variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
SERPINA1-R247C,SERPINA1,"Predicted to be damaging, other recessive mutations in this gene cause antitrypsin alpha 1 deficiency, and this variant is mentioned in an online database linking it to this disease.",High,Uncertain,Pathogenic,0.0026,Other,Recessive,Heterozygous,,rs28929470,4,chr14,94847386,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
C3-R102G,C3,"This variant (also called C3F) is common in Europeans (10.2% allele frequency), and is associated with age-related macular degeneration. In the US, 1.5% of adults over 40 have the disease, but the incidence increases strongly with age (>15% in women over 80). Assuming an average lifetime risk of ~10%, heterozygous individuals have a ~13% risk and homozygous have ~20%.",Moderate,Likely,Pathogenic,0.15,Hearing and vision,Complex/Other,Heterozygous,4427677;17634448,rs2230199,3,chr19,6718387,C,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
PPARG-P12A,PPARG,,Moderate,Uncertain,Not Reviewed,0.089,Other,Unknown,Heterozygous,16783862;17213274;17463248,rs1801282,3,chr3,12393125,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
COL4A1-Q1334H,COL4A1,"This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.",Low,Likely,Pathogenic,0.32,Heart and circulatory,Dominant,Heterozygous,10334796;18077766;20031579,rs3742207,2,chr13,110818598,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
MSR1-R293X,MSR1,"Associated with increased risk of Barrett's esophagus and/or esophageal cancer. Our very rough estimate is that the increased risk may be around 4x (25% risk of Barrett's esophagus, assuming population average is 5%, and 1.2% lifetime risk of esophageal cancer compared to average .4% risk).",Low,Likely,Pathogenic,0.0074,Cancer,Dominant,Heterozygous,12244320;12958598;21791690,rs41341748,2,chr8,16012594,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
NOD2-R702W,NOD2,"NOD2 encodes a protein involved in bacterial recognition. This variant is associated with Crohn's disease in European populations, but not in Korean or Japanese groups.",Low,Likely,Pathogenic,0.033,"Mouth, liver, and digestive",Complex/Other,Heterozygous,11875755;12202985;12529700,rs2066844,1,chr16,50745926,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
rs5186,,"This common noncoding genetic variant has an allele frequency of ~30% and is associated with an increased risk of hypertension. If ~25% of non-carriers have hypertension, Bonnardeaux et al's data predict ~4% increased risk of hypertension per copy of this variant. This SNP is in the 3' noncoding region of the AGTR1 transcript (angiotensin II type 1 receptor), also known as AT2R1 or AT1R, which is a target of hypertension drugs.",Low,Likely,Pathogenic,0.21,Drug response;Heart and circulatory,Unknown,Heterozygous,"8021009;
11250978;11593098;16046653;16675453;17668390",rs5186,2,chr3,148459988,C,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Heterozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
CLEC7A-Y238X,CLEC7A,This variant has been found to impair homan mucosal antifungal defense and was implicated in vulvovaginal candidiasis and mucocutaneous infections in a Dutch family.,Low,Uncertain,Pathogenic,0.063,Genital and urinary;Skin,Recessive,Homozygous,19864674,rs16910526,4,chr12,10271087,C,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
RNASEL-R462Q,RNASEL,"Associated with increased risk of prostate cancer in individuals who already have a family history of prostate cancer, but studies have been unable to replicate this finding in sporadic (non-familial) prostate cancer cases.",Low,Uncertain,Pathogenic,0.28,Cancer;Genital and urinary,Complex/Other,Homozygous,11941539;12022038;12415269;17407163,rs486907,2,chr1,182554557,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
KDR-C482R,KDR,"Hypothesized to cause a higher risk of benign neonatal hemangiomas (which are seen in 10% of children). However, observations lacked statistical significance.",Low,Uncertain,Pathogenic,0.021,Blood,Complex/Other,Heterozygous,18931684,rs34231037,3,chr4,55972946,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
TGIF1-P83Shift,TGIF1,"Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.",Low,Uncertain,Pathogenic,0.14,Nervous system,Complex/Other,Heterozygous,10556296,rs11571510,1,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Homozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
TPMT-Y240C,TPMT,"Alone, this variant is known as TPMT*3C -- but often, especially in Caucasians, it is found together with another nonsynonymous variant (A154T) to produce the TPMT*3A variant. Both variants are associated with loss of thiopurine methyltransferase (TPMT) activity, although *3C is milder than *3A. Inability to metabolize thiopurine drugs can lead to severe adverse reactions. Heterozygotes may be advised to take a reduced dosage due to reduced metabolism of the drug.",Low,Well-established,Pharmacogenetic,0.046,Drug response;Metabolism,Complex/Other,Heterozygous,15228163;15298741;20154640;20354201,rs1142345,2,chr6,18130918,C,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
TPMT-A154T,TPMT,"Usually this variant is found in combination Y240C, forming the TPMT*3A variant. When alone, this variant produces the *3B variant. Both variants are associated with loss of thiopurine methyltransferase (TPMT) activity. Inability to metabolize thiopurine drugs can lead to severe adverse reactions. Heterozygotes may be advised to take a reduced dosage due to reduced metabolism of the drug.",Low,Likely,Pharmacogenetic,0.028,Drug response;Metabolism,Recessive,Heterozygous,15228163;15298741;20154640;20354201,rs1800460,2,chr6,18139228,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
ABCC6-R1268Q,ABCC6,This common polymorphism appears to not have a significant phenotypic impact. A few studies report weak but significant associations with plasma lipids (in Inuits) and thalidomide toxicity.,Low,Uncertain,Pharmacogenetic,0.22,Metabolism,Unknown,Heterozygous,10811882;10913334;11776382;20038957,rs2238472,1,chr16,16251599,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Heterozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
DTNBP1-P272S,DTNBP1,Possibly a slight protective effect against colorectal cancer if homozygous.,Low,Uncertain,Protective,0.035,Cancer,Recessive,Heterozygous,17000706,rs17470454,2,chr6,15523448,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
BRCA2-T1915M,BRCA2,Serrano-Fern√°ndez et al. found this variant to be associated with a modest (OR = 1.61) but significant (P = 0.0007) reduction in breast cancer risk.  ,Low,Uncertain,Protective,0.021,Cancer,Unknown,Heterozygous,19030985,rs4987117,,chr13,32914236,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
IRS2-G1057D,IRS2,"a.k.a Gly1057Asp, insulin receptor substrate-2 IRS2. The rs1805097(G) allele is associated with the Gly, and the (A) allele with Asp. 
A longevity study concluded that rs1805097(A;A) individuals were about twice as likely to live over 85 y/o (odds ratio 2.03, CI:1.39-2.99, p = .0003). ",Low,Uncertain,Protective,0.23,Other,Unknown,Homozygous,19887537,rs1805097,,chr13,110435231,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
NEFL-S472Shift,NEFL,"Although a frameshift in this gene would be predicted to cause Charcot-Marie Neuropathy, this particular position appears to reflect a single base insertion error/mutation in the reference genome (in other words, normal individuals are always homozygous for a deletion at this position relative to reference). See chr8:24,811,060-24,811,080 annotations on UCSC.",Low,Likely,Benign,,Nervous system,Unknown,Homozygous,,rs11340767,,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
PMS2-P470S,PMS2,"Benign, common variant.",Low,Likely,Benign,0.37,Other,Unknown,Heterozygous,15256438,rs1805321,,chr7,6026988,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
SDHD-G12S,SDHD,"Reported to increase risk of Cowden disease, although this was already contradicted by a prior report of it as a non-pathogenic polymorphism. The report claiming a pathogenic effect (Ni et al.) may have had errors in analysis, and their observation of the variant in patients isn't different from the frequency of the variant in ExAC data.",Low,Likely,Benign,0.0081,Cancer,Unknown,Heterozygous,12696072;18678321,rs34677591,,chr11,111957665,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
COL7A1-P1277L,COL7A1,"Polymorphism, presumed benign.",Low,Uncertain,Benign,0.041,Other,Unknown,Heterozygous,,rs35761247,,chr3,48623124,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
TAS2R38-A49P,TAS2R38,"This variant is strongly associated with causing the ""taster"" phenotype of phenylthiocarbamine (PTC) in a dominant manner.",Low,Uncertain,Benign,0.43,Other,Unknown,Heterozygous,12595690;15883422;20675712,rs713598,,chr7,141673345,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Heterozygous,12595690;20675712,rs10246939,,chr7,141672604,C,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
PHYH-P29S,PHYH,"Probably benign. This variant was implicated as causing Refsum Disease in a recessive manner, but a subsequent publication noted that all instances were linked with other explanatory mutations. The high allele frequency of this variant in the population (7-13%) contradicts a pathogenic hypothesis.",Low,Uncertain,Benign,0.16,Nervous system,Unknown,Heterozygous,10767344;14974078,rs28938169,0,chr10,13340236,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
TPCN2-G734E,TPCN2,Pigmentation allele.,Low,Uncertain,Benign,0.29,Other,Unknown,Heterozygous,18488028,rs3829241,,chr11,68855363,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
WFS1-R456H,WFS1,Reported benign in ClinVar,Low,Uncertain,Benign,0.045,Other,Unknown,Heterozygous,,rs1801208,0,chr4,6302889,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
TYR-S192Y,TYR,This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).,Low,Uncertain,Benign,0.27,Skin,Unknown,Heterozygous,17952075;17999355,rs1042602,,chr11,88911696,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
RAPSN-R58C,RAPSN,Reported as non-pathogenic polymorphism. ,Low,Uncertain,Benign,0.078,Other,Unknown,Heterozygous,11791205,rs34312154,,chr11,47470345,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f04558aeff126939d311be95b6b55eaeb9266df7
